IndraLab

Statements

Pazopanib inhibits CTSB. 1 / 1

| 1

reach

"By contrast, treatment for 48h with pazopanib induces cathepsin B activation and autophagic cell death, markedly reversed by CA074-Me and 3-MA, cathepsin B and autophagic inhibitors, respectively."

23887605

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Pazopanib inhibits CTSB. 1 / 1

INDRA sources:

Databases

Reading